Coming soon Health Canada approves two Tetra Bio Pharma topicals for over-the-counter sales Treatments for back pain and hemorrhoids will hit shelves mid-2020, company says Nick LabaJanuary 17, 2020
Culture Victoria becomes first Canadian city to back exemption for unlicensed dispensary After a unanimous city council vote, Mayor Lisa Helps will write a letter to the province Nick LabaJanuary 10, 2020
Culture Green Day bassist backs first SEC private stock offering of a US cannabis cultivator Mike Dirnt, who has stake in the company, announced the offering of up to US$10 million Nick LabaJanuary 9, 2020
Canada Tilray to ship 2.5 tonnes of cannabis to Israel Canndoc, a subsidiary of InterCure, will later sell 5 tonnes of cannabis back to Tilray Michelle GamageJanuary 2, 2020
Data US cannabis testing services market will more than triple to US$409.3 million by 2027: report Intelligence firm Coherent Market Insights say the growth is due to an expanding patient base and nods from authorities Nick LabaDecember 17, 2019
International Peru passes long-awaited regulations to open medical cannabis market Domestic companies and big international players are already poised to cash in Nick LabaDecember 11, 2019
Medical and Pharmaceutical Americans battling depression twice as likely to use cannabis, study finds Almost 19 per cent of survey respondents with depression reported using pot over the last 30 days Jared GnamDecember 10, 2019
Legalization Over half of U.S. medical students unprepared to talk about cannabis: study Despite medical cannabis being legal since 2010, Washington, D.C., students are still in the dark Michelle GamageDecember 6, 2019
Coming soon Stat-tracking medical cannabis vaporizer passes key international safety tests RYAH Medtech is gearing up to enter more foreign markets and list on the CSE Nick LabaDecember 6, 2019
Medical and Pharmaceutical U.S. FDA gives rare designation to THC cancer drug in clinical trials Tetra Bio-Pharma’s stock continues to rise after announcing more trials at no additional cost to shareholders Nick LabaDecember 4, 2019